8:40am ET
Investing
J.P. Morgan’s Top Stock Picks for the Second Half of 2014
A new report from the equity strategy team at J.P. Morgan presents an extensive list of top names to buy for the next six months in a multitude of categories.
Companies
/Healthcare
Medtronic Plc
$91.23
â–² $1.26 (+1.40%) today
Markets closed · 2:57am ET
MDT Coverage
Page 12
8:35am ET
Investing
Top Analyst Upgrades and Downgrades: 3D Systems, BlackBerry, Coach, Oracle, Trina Solar, Kroger and More
These are the top Wall Street analyst upgrades, downgrades and initiations for Friday, June 20, 2014. They include 3D Systems, BlackBerry, Coach, Oracle, Trina Solar and Kroger.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Cisco, F5, GNC, Garmin, SunPower, Tyson and More
These are the top Wall Street analyst upgrades, downgrades and initiations seen on Wednesday, June 18, 2014. They include Cisco, F5 Networks, GNC, Garmin, SunPower and Tyson Foods.
9:05am ET
Investing
UBS New Stocks to Buy for Growth at a Reasonable Price
ThinkstockIf there was ever a time to get an update on one of the top lists of stocks to buy on Wall Street that we cover here at 24/7 Wall Street, now…
8:05am ET
Investing
Top Analyst Upgrades and Downgrades: DSW, Expedia, Orbitz, SanDisk, USG, Williams and More
These are the top Wall Street analyst upgrades, downgrades and initiations for Tuesday, June 17, 2014. They include DSW, Expedia, Orbitz, SanDisk, USG and Williams Companies.
8:20am ET
Investing
Top Analyst Upgrades and Downgrades: AMD, AmEx, Dish, Exelon, GNC, Medtronic, Micron and More
These are the top Wall Street analyst upgrades, downgrades and initiations for Monday, June 16, 2014. They include AMD, American Express, Dish Network, Exelon, GNC, Medtronic and Micron Technology.
7:50am ET
Health and Healthcare
Medtronic and Covidien Deal Is All About Taxes and Dividends
The $42.9 billion merger between medical device makers Medtronic and Covidien was officially confirmed early Monday morning. The deal is a so-called tax inversion.
Paul Ausick 10:20am ET
Health and Healthcare
Four Top Medical Device Stocks That Are Takeover Candidates
Here are four top medical device makers that the Leerink team thinks make sense as potential takeover candidates, but also have more than enough merit to stand on their own.
1:05pm ET
Health and Healthcare
Medical Device Maker’s IPO a Modest Success
ThinkstockSome initial public offerings (IPOs) are considered a huge success if the stock appreciates more than about 20% on its IPO date. To some, though, that’s an unsuccessful launch from the company’s…
Paul Ausick 8:05am ET
Investing
Oppenheimer’s Stocks to Buy That Yield More Than the S&P 500
Frank Golhen, via Wikimedia CommonsWith volatility edging ever higher, investors have to look for at least a synthetic hedge to help them should there be a sizable correction. One of the best…
8:30am ET
Investing
UBS Top Dividend Stocks to Buy as Quality Growth at a Reasonable Price
For some time we have kept a close eye on the UBS Quality Growth at a Reasonable Price list (Q-GARP) of stocks to buy. 24/7 Wall St. screened the list for the…
9:15am ET
Investing
Deutsche Bank’s Eight True Dividend Growth Stocks to Buy Now
In a new research report from Deutsche Bank, the equity strategists point that the companies that are maintaining and increasing share buybacks, plus maintaining and increasing dividends, are the stocks to buy…
8:05am ET
Investing
UBS Dividend Ruler Stocks to Buy for 2014 and Beyond
ThinkstockEquity investors are enjoying very nice gains in 2013. So far the S&P 500 is up 26.6%, the best performance since 1998. But the story is very different when UBS looked at…
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Lululemon, Priceline, Sprint, Tesla, Twitter and More
Jon OggEarnings season is now winding down and stocks keep challenging new all-time highs. Now investors and traders alike are starting to decide how to best position their assets for 2014. Each…
8:30am ET
Health and Healthcare
Top Oppenheimer Health Care Stocks to Buy for 2014
ThinkstockHealth care has been a top sector for investors this year. The research team at Oppenheimer continues to believe that health care remains well positioned to deliver further market-topping returns in 2014.…